IDx, Coralville, IA
IDx Technologies announces new appointments to its executive leadership team to accelerate product development and scale operations to accommodate increased market adoption of IDx-DR, the FDA-authorized autonomous AI system that detects diabetic retinopathy, a leading cause of blindness. Michael Abramoff, MD, PhD, Founder and CEO, succeeds Gary Seamans as Executive Chairman. John Bertrand succeeds Abramoff as CEO. Additional executive changes include the appointment of Seth Rainford as President and COO.
Newly appointed CEO Bertrand brings over a decade of healthcare technology experience to IDx, previously holding a variety of executive roles at Epic Systems. During his 13-year career with Epic, Bertrand led cross-functional teams in a variety of product, customer success, and business development roles with a focus on growth. Most recently Bertrand served as Executive in Residence at 8VC, a leading Silicon Valley venture capital firm focused on healthcare technology. His time in this space focused on the application of artificial intelligence and computer vision in healthcare.